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pDCParamyxovirus C protein targets the host interferon (IFN) system for virus immune evasion. To
identify its unknown anti-IFN activity, we examined the effect of Sendai virus C protein on
activation of the IFN-a promoter via various signaling pathways. This study uncovers a novel ability
of C protein to block Toll-like receptor (TLR) 7- and TLR9-dependent IFN-a induction, which is spe-
ciﬁc to plasmacytoid dendritic cells. C protein interacts with a serine/threonine kinase IKKa and
inhibits phosphorylation of IRF7. This anti-IFN activity of C protein is shared across genera of the
Paramyxovirinae, and thus appears to play an important role in paramyxovirus immune evasion.
Structured summary of protein interactions:
SeV C physically interacts with IKKalpha by anti tag coimmunoprecipitation (View interaction)
bPIV3 C physically interacts with IKKalpha by anti tag coimmunoprecipitation (1, 2)
NiV C physically interacts with IKKalpha by anti tag coimmunoprecipitation (1, 2)
MeV C physically interacts with IKKalpha by anti tag coimmunoprecipitation (1, 2)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Virus strategies against host interferon (IFN) system are crucial
for efﬁcient virus growth, and greatly affects virus pathogenesis.
Such anti-IFN strategies have been found exactly in the subfamily
Paramyxovirinae including parainﬂuenza viruses (PIVs), measles
virus (MeV), and emerging deadly viruses such as Nipah virus
(NiV) [1]. The Paramyxovirinae employ an accessory protein(s), V
and/or C, expressed from viral P gene mRNAs, as an IFN antagonist
[2]. Whereas V protein is expressed by most paramyxoviruses, Cprotein is encoded by only members that belong to three genera;
the Respirovirus, Morbillivirus, and Henipavirus.
IFN antagonism of C protein was primarily discovered from
studies on a prototype paramyxovirus, Sendai virus (SeV) (mouse
PIV type 1) [3,4]. It was found that SeV C protein blocked the
JAK-STAT pathway, which transmits signals from IFNs outside
the cell into promoters of the IFN-stimulated genes (ISGs) in
the nucleus [5,6]. Since ISGs include anti-viral proteins such as
double stranded (ds) RNA dependent protein kinase R (PKR),
the blockade of the JAK-STAT pathway results in prevention of
establishment of the IFN-mediated anti-viral state. The anti-IFN
activity uncovered next is to limit amounts of dsRNAs produced
during virus transcription and replication, thereby keeping
dsRNA dependent PKR inactive [7]. Since dsRNAs serve as path-
ogen-associated molecular patterns (PAMPs) to stimulate IFN
production, this ability also contributes to restriction of host
IFN production. In contrast to these unequivocal anti-IFN
activities, no conclusive evidence has been yet obtained for the
ability of SeV C protein to block signaling pathways that activate
interferon regulatory factor 3 (IRF3) involved in IFN-b production
[8–10]. Furthermore it remains to be determined whether C
protein blocks signaling pathways that activate IRF7 involved
in IFN-a production.
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PAMPs by pattern recognition receptors [11]. Cytoplasmic RNA
helicase retinoic acid-inducible gene-I (RIG-I) and melanoma
differentiation-associated gene 5 (MDA5) known as RIG-I-like
receptors (RLRs), and endosomal Toll-like receptor 3 (TLR3)
sense nucleic acids of RNA viruses as PAMPs and activate
IRF3 and IRF7 [12]. Both transcription factors induce IFN-b,
but production of IFN-a except for IFN-a4 subtype is regulated
by IRF7 but not IRF3 in the mouse [13]. Primary activation of
the RLR- or TLR3-dependent pathway results in induction of
IFN-b via activation of endogenous IRF3, because most cells ex-
press IRF3 but do not express a detectable level of IRF7. Once
IFN-b is produced, however, secreted IFN-b stimulates the
JAK-STAT pathway and activates transcription of ISGs including
IRF7. IRF7 is in turn activated through the RLR- or TLR3-depen-
dent pathway, resulting in IFN-a production. The RLR- and
TLR3-dependent pathways leading to activation of IRF7 are
basically the same as those activating IRF3, but a recent study
revealed a difference in a portion of molecules participating
in the signal transduction. Whereas tumor necrosis factor
receptor-associated 6 (TRAF6) is required for RLR-dependent
activation of IRF7, it is dispensable for RLR-dependent activa-
tion of IRF3 [14]. On the other hand, plasmacytoid dendritic
cells (pDCs), which constitutively express a high level of IRF7,
have a particular signaling pathway mediated by endosomal
TLR7 and TLR9 to produce a burst amount of IFN-a [15]. Recog-
nition of PAMPs by TLR7/9 results in activation of IRF7 via
kinases IjB kinase alpha (IKKa) and/or interleukin-1 receptor-
associated kinase 1 (IRAK1) [16].
In the present study, we examined effect of SeV C protein on
various signaling pathways that activate IRF7 involved in IFN-a
induction. Our study uncovered a novel inhibitory activity against
TLR7/9-dependent IFN-a induction. SeV C protein binds to a serine/
threonine kinase IKKa and inhibits phosphorylation of IRF7. These
features of C protein are shared across genera of the Paramyxovir-
inae, suggesting that the novel activity plays an important role in
paramyxovirus immune evasion.2. Materials and methods
2.1. Cells and plasmids
HEK293T and Vero cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium containing 2 mM L-glutamine, penicillin
(100 IU/ml), streptomycin (100 lg/ml), and 10% fetal bovine serum
[6,17]. pEFneo-IFN-b promoter stimulator-1 (IPS-1), pEFneo-FLAG-
TIR-domain-containing adapter-inducing interferon-b (TRIF), pEF-
neo-HA-MDA5, and pEFneo-HA-RIG-IN [N-terminal domain (aa
1–229) of RIG-I] were a gift from T. Komatsu [8,9]. pCAGGs-puro/
N-FLAG-NS3/4A and pCAGGs-SeV nucleocapsid protein (N) were
gifts from T. Abe [18] and T. Sakaguchi, respectively. IFN-a6 pro-
moter-driven luciferase reporter plasmid was created previously
by insertion of the mouse IFN-a6 promoter into the NheI/BglII site
of PGV-B2 reporter plasmid (Wako) [19,20]. The cDNA fragments
encoding other cellular or viral proteins with N- or C-terminal
myc, V5, or FLAG tag were created by using mouse intracellular
mRNAs, pCP721 containing the NiV phosphoprotein (P) gene
(kindly provided by L.-F. Wang), and viral genomic RNAs from
SeV Z strain, bovine PIV type 3 (bPIV3) 910 N strain and MeV
Edmonston strain, as a template, and then subcloned into a
multi-cloning site downstream of the cytomegalovirus enhancer
chicken b-actin hybrid promoter [21] of pCA7 [22] or pCAGGs. C
mutant proteins with F170S, K151A/E153A/R154A, or R173A/
E175A/E176A substitutions (CF170S, Cm5, and Cm8) [23,24] were
created as described previously [9].2.2. Reporter assay
HEK293T or Vero cells (1.5  105/well) in 24-well plates were
transfected with IFN-a6-promoter-driven reporter plasmid (80 ng/
well), pRL-TK (10 ng/well) (Promega) and various combinations of
plasmids using polyethyleneimine (Polysciences) [19,20]. The
amount of plasmids used was 25 ng/well for HA-RIG-IN, HA-
MDA5, and IPS-1, 5 ng/well for FLAG-TRIF, V5-myeloid differentia-
tion factor 88 (MyD88), V5-TRAF6, V5-IKKa, 15 ng/well for
myc-IRF7, and 50 ng/well for plasmids expressing viral protein.
The total mass of transfected DNA was held constant by the addi-
tion of the appropriate amount of pCA7 empty plasmid. At 20 h
post-transfection, cells were assayed for luciferase activity as pre-
viously described [25].
2.3. Measurement of IFN-a
Levels of human IFN-a were determined by using the human
IFN alpha enzyme-linked immunosorbent assay (ELISA) kit (PBL
Interferon Source, Piscataway, NJ).
2.4. Immunoprecipitation
HEK293T cells (5.0  105 cells/well) in a 6-well plate were
transfected with various combinations of plasmids (400 ng/well
each), using polyethyleneimine. At 24 h post-transfection, cells
were lysed in 400 ll of the lysis buffer [50 mM Tris–HCl pH 7.4,
150 mM NaCl, 1% TritonX-100, and protease inhibitor cocktail
(Roche)]. Cell lysates were then incubated with anti-FLAG mouse
monoclonal antibody (mAb) (1E6: Wako) or anti-V5 mouse mAb
(SV5-Pk1: Invitrogen) together with Protein G Sepharose 4 Fast
Flow (GE healthcare Bio-Science) at 4 C for 2 h. After washing
beads, proteins binding to the beads were subjected to immuno-
blot analysis.
2.5. Analysis of phosphorylated IRF7
HEK293T cells in a 24-well plate were transfected with various
combinations of plasmids. The amounts and the ratios of plasmids
were the same as those used in the reporter assay. At 20 h post-
transfection, cells were lysed in Laemmli sample buffer [50 mM
Tris–HCl pH 6.8, 2% sodium dodecyl sulfate (SDS), 0.1% bromophe-
nol blue, 10% glycerol and 5% 2-mercaptoethanol] and then
subjected to immunoblot analysis.
2.6. Immunoblot analysis
Samples were resolved by SDS-(10–12%) polyacrylamide gel
electrophoresis, and then electroblotted onto PVDF membranes
(Immobilon-P; Millipore). Subsequent procedures were performed
as described previously [20]. Anti-FLAG mAb, anti-V5 mAb, anti-
phospho-IRF7 (Ser471/472) rabbit polyclonal antibody (pAb)
(anti-pIRF7; Cell signaling technology), anti-SeV N rabbit pAb, or
anti-SeV C rabbit pAb, were used as the ﬁrst antibody.3. Results
3.1. A novel ability of SeV C protein to block TLR7/9-dependent IFN-a
induction
We previously employed a reconstitution system in HEK293T
cells to examine effect of paramyxovirus V proteins on TLR7/9-
dependent pathway [19,20,26], since pDCs are less amenable to
biochemical analysis. In this system, IRF7 in addition to a set of
upstream signaling molecules (MyD88, TRAF6, and IKKa) was
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ter plasmid and an internal control pRL-TK. A similar reconstitu-
tion system was applied to studies on RLR- and TLR3-dependent
IFN-a induction [8,9]. To stimulate RLR-dependent pathway, RIG-
IN (constitutive active form of RIG-I), MDA5, and a mitochondrial
adaptor molecule IPS-1 were used (Fig. 1A–C). On the other hand,
a cytoplasmic adaptor molecule TRIF was utilized to stimulate
TLR3-dependent pathway (Fig. 1D).
Expression of RIG-IN, which activates endogenous IRF3, re-
sulted in no activation of the IFN-a6 promoter, unless IRF7 was
co-expressed (Fig. 1A). Similar results were obtained for MDA5,
IPS-1 and TRIF (Fig. 1B–D), indicating no response of the IFN-a6
promoter to endogenous IRF3 in HEK293T cells. Expression of
IRF7 alone resulted in slight activation of the IFN-a6 promoter.
Whereas co-expression of RIG-IN, MDA5, IPS-1, and TRIF strikingly
enhanced the IFN-a6 promoter activation, this enhancement ex-
cept for a case of TRIF was suppressed by HCV NS3/4A, which
cleaves and inactivates IPS-1 (Fig. 1A–D) [27,28]. Previous studies
demonstrated that paramyxovirus V protein targeted MDA5 for
inhibition of MDA5-dependent IFN-b induction [29]. As expected,
MDA5-mediated IFN-a6 promoter activation was suppressed by
SeV V protein (Fig. 1B). On the other hand, no suppression of
RIG-IN-, MDA5-, IPS-1-, and TRIF-induced IFN-a activation was ob-
served for SeV C protein as well as SeV N and P proteins (Fig. 1A–
D), consistent with previous observations [8].
We next examined effect on TLR7/9-dependent IFN-a induc-
tion. A previous study uncovered an anti-IFN activity of SeV P
and V proteins against TLR7/9-dependent IFN-a induction [19].
Indeed expression of the P and V proteins signiﬁcantly inhibited
IFN-a6 promoter activation induced by transfection with MyD88,
TRAF6, and IKKa together with IRF7 (Fig. 1E). ComparableFig. 1. Effect of SeV C protein on IFN-a6 promoter activation via RLR-, TLR3-, or TLR7/9-de
with (A–E) or without (F) IFN-a6-promoter-driven reporter plasmid and pRL-TK. At 20 h p
of the culture media (F) was determined.inhibitory effect was observed for SeV C protein. This inhibition
was further conﬁrmed by ELISAs for IFN-a secreted from transfec-
ted HEK293T cells (Fig. 1F). These results suggest that SeV C pro-
tein inhibits TLR7/9-dependent IFN-a induction. Stimulation of
TLR7/9-dependent pathway induces IFN-a, which in turn activates
the IRF7 gene via the JAK-STAT pathway. Since the JAK-STAT path-
way is blocked by SeV C protein, this blockade may affect total
amount of IRF7, thereby lowering activation of the IFN-a promoter.
To exclude this possibility, Vero cells, which never produce IFNs,
were used instead. Even in Vero cells, similar results were obtained
(Fig. 2A). Moreover C mutant proteins, CF170S, Cm5, and Cm8, which
lack the ability to block the JAK-STAT pathway [3,24], were found
to have the inhibitory activity comparable to wild type C (Fig. 2B).
These results demonstrate that the novel inhibitory activity is
independent of the ability to block the JAK-STAT pathway.
3.2. SeV C protein binds to IKKa and inhibits phosphorylation of IRF7
To identify a molecular target of SeV C protein, co-immunopre-
cipitation experiments were performed. V5-tagged MyD88, TRAF6,
IKKa, or IRF7 was transfected into HEK293T cells together with
FLAG-tagged SeV C, and transfected cells were subjected to
immunoprecipitation. As shown in Fig. 3A, FLAG-tagged C was
co-immunoprecipitated with anti-V5 antibody in cells transfected
with V5-tagged IKKa, but not V5-tagged MyD88, TRAF6 and IRF7.
Conversely, not only V5-tagged IKKa (Fig. 3B) but also endogenous
IKKa (Fig. 3C) was co-immunoprecipitated with anti-FLAG anti-
body. These results suggest that IKKa is a candidate target of SeV
C protein.
Since IKKa is involved in phosphorylation of IRF7 [30], we
examined effect of SeV C protein on phosphorylation of IRF7. Anpendent pathway. HEK293T cells were transfected with indicated plasmids together
ost-transfection, relative luciferase activity of cell lysates (A–E) or the level of IFN-a
Fig. 2. Effect of SeV C or mutant C proteins on IFN-a6 promoter activation via TLR7/9-dependent pathway in Vero or HEK293T cells. Vero (A) or HEK293T (B) cells were
transfected with indicated plasmids together with IFN-a6-promoter-driven reporter plasmid and pRL-TK. At 20 h post-transfection, relative luciferase activity was
determined.
Fig. 3. Interaction of SeV C protein with IKKa. HEK293T cells were transfected with indicated plasmids. At 24 h post-transfection, cells were lysed in the lysis buffer. N-
terminal V5-tagged (A) or FLAG-tagged proteins (B and C) were immunoprecipitated (IP), and then subjected to immunoblot analysis (IB). An asterisk indicates position of the
antibody heavy chain.
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lated form of IRF7. IRF7 was present predominantly in an
unphosphorylated form in cells transfected with IRF7 alone
(Fig. 4). Co-expression of MyD88, TRAF6 and IKKa enhanced the le-
vel of phosphorylated IRF7, whereas this enhancement was strik-
ingly suppressed by co-expression of C, suggesting that SeV C
protein inhibits IKKa-mediated phosphorylation of IRF7. Elevation
of the IRF7 expression level was reproducibly observed in cells co-
transfected with the upstream signaling molecules regardless of
the presence or absence of viral protein, although the reason is
unknown.
3.3. Y1 and Y2 bind to IKKa but exhibit less ability to inhibit TLR7/9-
dependent IFN-a induction
Not only full size C (aa 1–204) but also Y1 (aa 23–204) and Y2
(aa 29–204), N-terminally deleted forms of C, are expressed in SeV-
infected cells [31]. Co-immunoprecipitation experiments using
cells transfected with Y1 or Y2 revealed the interaction of Y1 andY2 with IKKa (Fig. 5A and B), indicating that the N-terminal region
of C is not required for binding to IKKa. Nevertheless, Y1 and Y2
showed less ability to inhibit TLR7/9-dependent IFN-a induction,
compared with full size C (Fig. 5C). In accordance with magnitude
of their inhibitory activity, IRF7 phosphorylation was less inhibited
(Fig. 5D). These results indicates that the N-terminal region of C is
not required for binding to IKKa, but partly involved in the ability
to block TLR7/9-dependent IFN-a induction.
3.4. The novel activity of C protein is shared across genera
The subfamily Paramyxovirinae consists of seven distinct gen-
era, but only members of the Respirovirus, Morbillivirus, and Heni-
pavirus genera have acquired the C open reading frame (ORF) in
the P gene during evolution. To determine whether the novel
inhibitory activity is shared across genera, we examined effect of
the C proteins of bPIV3 of the same Respirovirus, MeV of theMorbil-
livirus, and NiV of the Henipavirus. As shown in Fig. 6A, not only
bPIV3 C but also MeV and NiV C exhibited a similar inhibitory
Fig. 4. Effect of SeV C protein on phosphorylation of IRF7 via TLR7/9-dependent
pathway. HEK293T cells were transfected with indicated plasmids. At 20 h post-
transfection, cells were lysed in Laemmli sample buffer and then subjected to
immunoblot analysis (IB) with speciﬁc antibodies including anti-phospho-IRF7
antibody.
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precipitation experiments and immunoblot analysis showed that
all the C proteins were capable of binding to IKKa (Fig. 6B and
C), and inhibited phosphorylation of IRF7 (Fig. 6D). These results
suggest that the novel anti-IFN activity and its underlying mecha-
nism are conserved during evolution.Fig. 5. Effect of Y1 and Y2 on IFN-a6 promoter activation via TLR7/9-dependent pathw
without (A, B and D) IFN-a6-promoter-driven reporter plasmid and pRL-TK. (A and B) At
proteins were immunoprecipitated (IP) and then subjected to immunoblot analysis
determined. (D) At 20 h post-transfection, cells were lysed in Laemmli sample buffer, and
An asterisk indicates position of the antibody light chain.4. Discussion
Paramyxovirus C proteins are expressed from mRNAs of the P
gene through the use of an alternative initiation codon, with the
C ORF being in the +1 reading frame relative to the P ORF [1].
Although their coding strategy is shared across genera, amino acid
sequences of C protein are extremely diverse and there is at most
20% amino acid sequence identity between C proteins of any two
genera [31]. It is thus unclear whether C protein is evolved from
a common ancestral origin across genera. The present study uncov-
ered a novel inhibitory activity of SeV C protein against TLR7/9-
dependent IFN-a induction, and further revealed that the novel
anti-IFN activity of C protein was shared across genera. In addition,
all the C proteins belonging to a separate genus interacted with
IKKa and inhibited phosphorylation of IRF7, suggesting that they
share a common underlying mechanism. These ﬁndings suggest
that there is a common ancestral C origin of the Respirovirus, Mor-
billivirus, and Henipavirus, and the novel anti-IFN activity is con-
served during evolution because of its important role in virus
immune evasion. Functional kinship of the C proteins between
genera was also observed for another anti-IFN ability to limit
dsRNA production [32,33]. In contrast, the ability to block the
JAK-STAT pathway may be genus-speciﬁc [34–38], suggesting that
it might have been independently acquired after the common
ancestral C origin split into three genera.
The present study does not provide sufﬁcient evidence for a
molecular target of C protein. It is possible that signaling molecules
other than IKKa is involved in the underlying mechanism. To ob-
tain convincing evidence, we will need to create several C mutant
proteins that lack the binding capacity for the target molecule.
More important question is why particular paramyxoviruses haveay. HEK293T cells were transfected with indicated plasmids together with (C) or
24 h post-transfection, cells were lysed in the lysis buffer. N-terminal FLAG-tagged
(IB). (C) At 20 h post-transfection, relative luciferase activity of cell lysates was
then subjected to IB with speciﬁc antibodies including anti-phospho-IRF7 antibody.
Fig. 6. Effect of bPIV3, MeV, and NiV C proteins on IFN-a6 promoter activation via TLR7/9-dependent pathway. HEK293T cells were transfected with indicated plasmids
together with (A) or without (B–D) IFN-a6-promoter-driven reporter plasmid and pRL-TK. (A) At 20 h post-transfection, relative luciferase activity of cell lysates was
determined. (B and C) At 24 h post-transfection, cells were lysed in the lysis buffer. C-terminal FLAG- or V5-tagged proteins were immunoprecipitated (IP) and then subjected
to immunoblot analysis (IB). (D) At 20 h post-transfection, cells were lysed in Laemmli sample buffer, and then subjected to IB with speciﬁc antibodies including anti-
phospho-IRF7 antibody. An asterisk indicates position of the antibody light chain.
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tribute to better understanding of paramyxovirus immune evasion.
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